EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Human Leukocyte Antigen DRB1 Genetic Polymorphism on Anti-Cyclic Citrullinated Peptide (ANTI-CCP) and Rheumatoid Factor (RF) Expression in Rheumatoid Arthritis (RA) Patients

Yu-Chia Chen, Chung-Ming Huang, Ting-Yuan Liu iD, Ning Wu, Chia-Jung Chan, Peng-Yu Shih, Hsin-Han Chen, Shih-Yin Chen iD, Fuu-Jen Tsai iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241512036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yu-Chia Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Million-Person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Rheumatoid Factor, HLA-DRB1 Chains, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University Hospital, China Medical University Hospital in Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a systemic disease characterized by non-infectious inflammation of the joints and surrounding tissues, which can cause severe health problems, affect the patient’s daily life, and even cause death. RA can be clinically diagnosed by the occurrence of blood serological markers, rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (anti-CCP). However, about 20% of RA patients exhibit negative results for both markers, which makes RA diagnosis difficult and, therefore, may delay the effective treatment. Previous studies found some evidence that human leukocyte antigen (HLA)-related genes might be the susceptibility genes for RA and their polymorphisms might contribute to varieties of susceptibility and disease severity. This study aimed for the genetic polymorphisms of the RA patient genome and their effects on the RA patient’s serological makers, RF and anti-CCP. A total of 4580 patients’ electronic medical records from 1992 to 2020 were retrieved from the China Medical University Hospital database. The most representative single-nucleotide polymorphisms (SNPs) were identified through a genome-wide association study (GWAS) followed by enzyme-linked immunosorbent assay (ELISA) validation using the blood from 30 additional RA patients. The results showed significant changes at the position of chromosome 6 with rs9270481 being the most significant locus, which indicated the location of the HLA-DRB1 gene. Further, patients with the CC genotype at this locus were more likely to exhibit negative results for RF and anti-CCP than those with the TT genotype. The C allele was also more likely to be associated with negative results for RF and anti-CCP. The results demonstrated that a genetic polymorphism at rs9270481 affected the expression of RF and anti-CCP in RA patients, which might indicate the necessity to develop a personalized treatment plan for each individual patient based on the genetic profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidRheumatoid FactorHLA-DRB1 ChainsPolymorphism, Single NucleotideAnti-Citrullinated Protein AntibodiesPeptides, CyclicHumansFemaleMaleMiddle AgedGenetic Predisposition to DiseaseAdultGenome-Wide Association StudyAgedGenotypeBiomarkersAlleles

Stichwörter der Autor:innen

anti-cyclic citrullinated peptide antibodygenome-wide association study (GWAS)human leukocyte antigen DRB1phenome-wide association studies (PheWASs)rheumatoid arthritisrheumatoid factor

Substanzen

Rheumatoid FactorHLA-DRB1 ChainsAnti-Citrullinated Protein AntibodiesPeptides, Cycliccyclic citrullinated peptideBiomarkers

Autor:innen und Institutionen

  • Million-Person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan.
  • Division of Immunology and Rheumatology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
  • School of Chinese Medicine, China Medical University, Taichung 404, Taiwan.
  • Department of Biological Sciences, Southeastern Oklahoma State University, Durant, OK 74701, USA.
  • Genetics Center, Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan.
  • Division of Plastic and Reconstructive Surgery, China Medical University Hospital, Taichung 404, Taiwan.

ORCID-Profile: Ting-Yuan Liu, Shih-Yin Chen, Fuu-Jen Tsai

Förderung

  • China Medical University Hospital
  • China Medical University Hospital in Taiwan

Zitieren

APA

Chen, Y. C., Huang, C. M., Liu, T. Y., Wu, N., Chan, C. J., Shih, P. Y., Chen, H. H., Chen, S. Y., & Tsai, F. J. (2023). Effects of Human Leukocyte Antigen DRB1 Genetic Polymorphism on Anti-Cyclic Citrullinated Peptide (ANTI-CCP) and Rheumatoid Factor (RF) Expression in Rheumatoid Arthritis (RA) Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512036

Vancouver

Chen YC, Huang CM, Liu TY, Wu N, Chan CJ, Shih PY, et al. Effects of Human Leukocyte Antigen DRB1 Genetic Polymorphism on Anti-Cyclic Citrullinated Peptide (ANTI-CCP) and Rheumatoid Factor (RF) Expression in Rheumatoid Arthritis (RA) Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512036

BibTeX
@article{Chen2023,
  author = {Chen, Yu-Chia and Huang, Chung-Ming and Liu, Ting-Yuan and Wu, Ning and Chan, Chia-Jung and Shih, Peng-Yu and Chen, Hsin-Han and Chen, Shih-Yin and Tsai, Fuu-Jen},
  title = {Effects of Human Leukocyte Antigen DRB1 Genetic Polymorphism on Anti-Cyclic Citrullinated Peptide (ANTI-CCP) and Rheumatoid Factor (RF) Expression in Rheumatoid Arthritis (RA) Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241512036}
}
Kostenlos starten →